Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Investor Investigation Concerning Potential Breaches Of Fiduciary Duties Announced

If you purchased shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and currently hold any of those NASDAQ:ALXN shares, you have certain options and you should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Company Name(s):

Alexion Pharmaceuticals

Affected Securities:

NASDAQ: ALXN

November 17, 2014 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Alexion Pharmaceuticals.

The investigation by a law firm concerns whether certain Alexion Pharmaceuticals officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Alexion Pharmaceuticals, Inc. reported that its annual Total Revenue rose from over $1.13 billion in 2012 to over $1.55 billion in 2013 while its respective Net Income declined from $254.82 million to $252.90 million. Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) grew from $88.49 per share in June 2013 to as high as $19.570 per share on November 11, 2014.